When was Liverpool ChiroChem founded?

Liverpool ChiroChem was founded in 2014 and raised its 1st funding round 1 year after it was founded.

Where is Liverpool ChiroChem located?

Liverpool ChiroChem is headquartered in Liverpool, United Kingdom. It is registered at DOUGLAS BANK HOUSE,WIGAN LANE,WIGAN,ENGLAND,WN1 2TB.

Who is the current CEO of Liverpool ChiroChem?

Jianjun Wu and Paul Colbon s of Liverpool ChiroChem.

How many employees does Liverpool ChiroChem have?

As of Dec 31, 2018, the latest employee count at Liverpool ChiroChem is 14.

Is Liverpool ChiroChem a funded company?

Liverpool ChiroChem is a funded company, having raised a total of $11.1M across 6 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jul 09, 2015.

How much is Liverpool ChiroChem worth?

The last known valuation of Liverpool ChiroChem was £***** as of Oct 31, 2022.

When was the latest funding round of Liverpool ChiroChem?

Liverpool ChiroChem's latest funding was a $***** Series A round on Nov 10, 2022, with participation from 3 investors. Its primary sector is Biopharma Outsourcing. In United Kingdom, the Biopharma Outsourcing sector has seen $34M in funding in 2026 to date.

Where does Liverpool ChiroChem rank among its competitors?

Liverpool ChiroChem ranks 17th amongst 232 active competitors, of which 22 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was ChemLex, which secured $45M in Dec, 2025.

Who are the top competitors of Liverpool ChiroChem?

Liverpool ChiroChem's top competitors include Sai Life Sciences, NFIL and Bioduro. Among them, ChemLex secured the most recent funding round in December, 2025.

Liverpool ChiroChem - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Liverpool ChiroChem is focussed on producing and supplying small organic molecules for biotech/pharmaceutical companies which can be used as building blocks, fragments and screening compounds. Its initial focus is on the (a)chiral piperidines, which have applications in drug discovery and development. Its technology is based on the research in the areas of asymmetric hydrogenation and Pd-coupling. It also provides collaborate services to optimise key steps in synthetic routes.

Website: liverpoolchirochem.com
Social
Email ID: *****@liverpoolchirochem.co.uk
Registered Address: DOUGLAS BANK HOUSE,WIGAN LANE,WIGAN,ENGLAND,WN1 2TB

Key Metrics

Founded Year

2014

Location

Liverpool, United Kingdom

Stage

Acquired

Total Funding

$11.1M in 6 rounds

Latest Funding Round

Series A, Nov 10, 2022, $*****

Last Known Valuation

£***** as on Oct 31, 2022

Investors

Praetura Ventures & 5 more

Ranked

17^th among 232 active competitors

Employee Count

14 as on Dec 31, 2018

Similar Companies

Sai Life Sciences & 269 more

Exit Details

Acquired by XtalPi (Jun 13, 2025)

View Liverpool ChiroChem's full profile

Liverpool ChiroChem is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
LIVERPOOL CHIROCHEM LIMITED CIN: 8900140 , United Kingdom, Active	Feb 17, 2014	-	25 (As on Dec 31, 2023)

Liverpool ChiroChem got acquired by XtalPi on Jun 13, 2025.

Click here to take a look at Liverpool ChiroChem's acquisition in detail

Liverpool ChiroChem has raised a total funding of $11.1M over 6 rounds. Its first funding round was on Jul 09, 2015. Its latest funding round was a Series A round on Nov 10, 2022 for $*****. 3 investors participated in its latest round. Liverpool ChiroChem has 6 institutional investors.

Here is the list of recent funding rounds of Liverpool ChiroChem:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 10, 2022	8308868	Series A	3812583	3186863	5459924	1928730
Apr 12, 2021	6805482	Series A	2400573	5511240	7369446	Gov
May 04, 2020	9341694	Series A	9481309	6425411	Deepbridge Capital & 1 more	Maven Capital Partners

Access funding benchmarks and valuations. Sign up today!

View details of Liverpool ChiroChem's funding rounds and investors

The founders of Liverpool ChiroChem are Jianjun Wu and Paul Colbon.

Here are the details of Liverpool ChiroChem's key team members:

Jianjun Wu: CEO and Co-Founder of Liverpool ChiroChem.
Paul Colbon: Co-Founder and CEO of Liverpool ChiroChem.

View details of Liverpool ChiroChem's Founder profiles and Board Members

Liverpool ChiroChem's employee count trend

Liverpool ChiroChem has 14 employees as of Dec 18. Here is Liverpool ChiroChem's employee count trend over the years:

Employee count trend for Liverpool ChiroChem

Uncover Liverpool ChiroChem's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Liverpool ChiroChem include Sai Life Sciences, NFIL and Bioduro. Here is the list of Top 10 competitors of Liverpool ChiroChem, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Sai Life Sciences 1999, Hyderabad (India), Public	Provider of drug discovery, development, and manufacturing of complex small molecules	$108M	HBM Healthcare Investments, Sequoia Capital ... & 123 others	66/100
2nd	NFIL 1967, Mumbai (India), Public	CRAMS company specialising in the custom chemical synthesis and manufacturing of fluorinated compounds	-	-	50/100
3rd	Bioduro 2005, San Diego (United States), Acquired	Global CRDMO providing integrated drug discovery, development, and manufacturing services	-	BridgeWest Group	49/100
4th	IRBM 2010, Pomezia (Italy), Funding Raised	Integrated drug discovery and preclinical development service provider	-	BioVaria, Europa	48/100
5th	ChemLex Shanghai (China), Series B	Provider of consulting services in the field of chemical research and development through artificial intelligence chemical synthesis	$71M	LYFE Capital, Qiming Venture Partners & 3 others	46/100
6th	Alzheimer's Drug Discovery 1998, New York City (United States), Funding Raised	Foundation aims to discover drugs to prevent, treat, and cure alzheimer's disease	-	HHS	44/100
7th	48Hour Discovery 2017, Edmonton (Canada), Funding Raised	Developer of molecular discovery platform	-	K-Startup Grand Challenge, Edmonton	44/100
8th	Vernalis 1999, Wokingham (United Kingdom), Acquired	Drugs for the treatment of cough, asthma, migraine and cancer.	-	Invesco Mutual Fund, Woodford Investment Management ... & 4 others	43/100
9th	Acies Bio 2006, Ljubljana (Slovenia), Seed	Provider of drug discovery and development services to pharmaceutical, biotech, and food industries	-	ADM, EIC Fund & 1 others	42/100
10th	Wilmington Pharmatech 2003, Newark (United States), Acquired	Integrated CRO/CMO providing API, custom synthesis, and analytical services	-	-	42/100
17th	Liverpool ChiroChem 2014, Liverpool (United Kingdom), Acquired	Small organic molecule supplier for biotech/pharmaceutical R&D	$11.1M	Praetura Ventures, Gov & 4 others	38/100